Glenn E. Rodey

3.4k total citations
88 papers, 2.7k citations indexed

About

Glenn E. Rodey is a scholar working on Immunology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Glenn E. Rodey has authored 88 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Immunology, 19 papers in Hematology and 17 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Glenn E. Rodey's work include T-cell and B-cell Immunology (27 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Immune Cell Function and Interaction (16 papers). Glenn E. Rodey is often cited by papers focused on T-cell and B-cell Immunology (27 papers), Monoclonal and Polyclonal Antibodies Research (17 papers) and Immune Cell Function and Interaction (16 papers). Glenn E. Rodey collaborates with scholars based in United States, United Kingdom and Denmark. Glenn E. Rodey's co-authors include Thomas Fuller, Robert A. Good, Alfred A. Rimm, D. Phelan, Richard H. Aster, Howard M. Gebel, Benjamin D. Schwartz, René J. Duquesnoy, H. Kent Holland and Anne Fuller and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Glenn E. Rodey

87 papers receiving 2.4k citations

Peers

Countries citing papers authored by Glenn E. Rodey

Since Specialization

Citations

This map shows the geographic impact of Glenn E. Rodey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn E. Rodey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn E. Rodey more than expected).

Fields of papers citing papers by Glenn E. Rodey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn E. Rodey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn E. Rodey. The network helps show where Glenn E. Rodey may publish in the future.

Co-authorship network of co-authors of Glenn E. Rodey

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn E. Rodey. A scholar is included among the top collaborators of Glenn E. Rodey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn E. Rodey. Glenn E. Rodey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HLA Alloantibodies and the Mechanism of the Antiglobulin-Augmented Lymphocytotoxicity Procedure 1997 ·Human Immunology ·Thomas Fuller, Anne Fuller, (unknown), Glenn E. Rodey	40
2	Low incidence of red cell and HLA antibody formation by bone marrow transplant patients 1995 ·Transfusion ·(unknown), (unknown), Martin Allen, (unknown), (unknown), H. Kent Holland, John R. Wingard, Robert A. Bray, Glenn E. Rodey, Christopher D. Hillyer	45
3	Epitope specificity of HLA class I alloantibodies I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients 1994 ·Human Immunology ·Glenn E. Rodey, John F. Neylan, John D. Whelchel, (unknown), Robert A. Bray	114
4	Anti‐idiotypic antibodies and regulation of immune responses 1992 ·Transfusion ·Glenn E. Rodey	12
5	Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes 1990 ·Human Immunology ·Anne Fuller, Glenn E. Rodey, Peter Parham, Thomas Fuller	55
6	Characterization of human cardiac infiltrating cells posttransplantation: II. CD4+ cloned T-cell lines with “anti-idiotype”-like reactivity 1990 ·Human Immunology ·(unknown), Kirk R. Kanter, Omar M. Lattouf, Glenn E. Rodey, K W Sell, Aftab A. Ansari	4
7	THE DEVELOPMENT AND SPECIFICITY OF ANTIIDIOTYPIC ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS RECEIVING SINGLE-DONOR BLOOD TRANSFUSIONS 1989 ·Transplantation ·D. Phelan, Glenn E. Rodey, Charles B. Anderson	31
8	ASSOCIATION OF ANTIIDIOTYPIC ANTIBODY WITH SUCCESSFUL SECOND TRANSPLANT OF A KIDNEY SHARING HLA ANTIGENS WITH THE PREVIOUS HYPERACUTELY REJECTED FIRST KIDNEY 1989 ·Transplantation ·Glenn E. Rodey, D. Phelan	24
9	Community outbreak of thyrotoxicosis: Epidemiology, immunogenetic characteristics, and long-term outcome 1988 ·The American Journal of Medicine ·Janet S. Kinney, Eugene S. Hurwitz, Daniel B. Fishbein, Paul F. Pinsky, Dale N. Lawrence, Larry J. Anderson, Gary P. Holmes, (unknown), Lawrence B. Schonberger, Paul D. Woolf, (unknown), (unknown), (unknown), Glenn E. Rodey, (unknown)	23
10	Preliminary report of the American Society for Histocompatibility and Immunogenetics phase I workshop on HLA class I public epitopes. 1987 ·PubMed ·Glenn E. Rodey, Thomas Fuller	7
11	Is It Possible to Formulate a Unified Concept for the Biological Function of the Major Histocompatibility Complex (MHC)? 1985 ·Vox Sanguinis ·Jan Klein, N Mitchison, Glenn E. Rodey, J. J. van Rood, Morten Simonsen	1
12	Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis. 1982 ·The Journal of Experimental Medicine ·Robert W. Karr, Carol C. Kannapell, Judy Stein, Thomas Fuller, R.J. Duquesnoy, Glenn E. Rodey, Douglas L. Mann, Howard M. Gebel, Brett D. Schwartz	24
13	ANTIGENIC SPECIFICITY OF ANTIBODY REACTIVE IN THE ANTIGLOBULIN-AUGMENTED LYMPHOCYTOTOXICITY TEST 1982 ·Transplantation ·Thomas Fuller, D. Phelan, Howard M. Gebel, Glenn E. Rodey	113
14	A study of HLA-A, B, C, and DR specificities in pigeon breeder's disease. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Glenn E. Rodey, Jordan N. Fink, Susanne Koethe, Donald P. Schlueter, Jan Witkowski, (unknown), AA Rimm, Vernon L. Moore	20
15	Public antigenic determinant on a family of HLA-B molecules. 1979 ·Journal of Clinical Investigation ·Benjamin D. Schwartz, (unknown), Glenn E. Rodey	54
16	Alternative complement pathway activity in sera from patients with sickle cell disease. 1976 ·PubMed ·Susanne Koethe, James T. Casper, Glenn E. Rodey	51
17	Alpha 1 antitrypsin deficiency: a study of the relationship between the Pi system and genetic markers. 1975 ·PubMed ·Markus Schmitt, Ruth B. Phillips, (unknown), Glenn E. Rodey	3
18	Procurement and Identification of HL‐A Lymphocytotoxic Antibodies in Sera of Nonpregnant, Multiparous Blood Donors 1974 ·Transfusion ·Glenn E. Rodey, Jacek Kunicki, Joanna Anderson, Richard H. Aster	4
19	HISTOCOMPATIBILITY ANTIGENS OF HUMAN PLASMA 1973 ·Transplantation ·Richard H. Aster, (unknown), Glenn E. Rodey	46
20	Studies of the relation of thymus-dependent lymphoid system and pituitary gland. Abstr. 1969 ·The Mouseion at the JAXlibrary (Jackson Laboratory) ·René J. Duquesnoy, Glenn E. Rodey, (unknown), R. A. Good	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact